PCM
CRTX

Prelude Capital Management’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Prelude Capital Management’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-11,700
Closed -$111K – 2338
2013
Q4 		$111K Sell
11,700
-8,569
-42% -$81.1K 0.02% 827
2013
Q3 		$191K Buy
+20,269
New +$183K 0.03% 558

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Prelude Capital Management's CRTX Position: Q1 2014 in Review

Prelude Capital Management sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 11,700 shares — an estimated $111K sold.

Prelude Capital Management first reported a position in CRTX in Q3 2013 and held it in 2 quarters. The position peaked at $191K in Q3 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Prelude Capital Management reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Prelude Capital Management sold 11,700 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $111K.
  • Prelude Capital Management first reported a position in CORNERSTONE THERAPEUTICS INC in Q3 2013 and held it in 2 quarters.
  • Prelude Capital Management's CORNERSTONE THERAPEUTICS INC position peaked at $191K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Prelude Capital Management's 13F filing for Q1 2014, filed 15 May 2014.